#$%^&*AU2008233025B820130725.pdf#####Therapeutic and Prophylactic Use and Method Abstract Described herein is the use of therapeutic human albumin for the preparation of a drug for the treatment of patients suffering from cognitive disorders, in which the model of administration of the 5 drug comprises the administration to the patient for a minimum of three successive times of a therapeutically effective amount of human therapeutic albumin by plasma exchange and/or intravenous perfusion, independently of the content of As in the patient's blood.
